NCT07579169 Comparison of Operator Radiation Exposure During Percutaneous Coronary Intervention Between Left Distal and Right Conventional Radial Access
| NCT ID | NCT07579169 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yonsei University |
| Condition | Radiation Exposure |
| Study Type | INTERVENTIONAL |
| Enrollment | 748 participants |
| Start Date | 2026-06-18 |
| Primary Completion | 2029-04-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 748 participants in total. It began in 2026-06-18 with a primary completion date of 2029-04-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the operator's radiation exposure between left distal radial access (LDRA) and right transradial access (RTRA) in patients undergoing percutaneous coronary intervention (PCI).
Eligibility Criteria
Inclusion Criteria: 1. Patients aged 19 years or older 2. Patients scheduled for PCI Exclusion Criteria: 1. Non-palpable left distal radial artery pulse 2. Non-palpable right radial artery pulse 3. Presence of arteriovenous fistula 4. Need for femoral access as determined by the investigator 5. Refusal to provide informed consent 6. Pregnant or breastfeeding women
Contact & Investigator
Yongcheol Kim, MD, PhD
PRINCIPAL INVESTIGATOR
Severance Hospital
Frequently Asked Questions
Who can join the NCT07579169 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Radiation Exposure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07579169 currently recruiting?
Yes, NCT07579169 is actively recruiting participants. Contact the research team at yongcheol@yuhs.ac for enrollment information.
Where is the NCT07579169 trial being conducted?
This trial is being conducted at Osaka, Japan, Yongin-si, South Korea, Daegu, South Korea, Jeonju, South Korea.
Who is sponsoring the NCT07579169 clinical trial?
NCT07579169 is sponsored by Yonsei University. The principal investigator is Yongcheol Kim, MD, PhD at Severance Hospital. The trial plans to enroll 748 participants.